Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all?

Head and Neck

Volumn 28, Issue 2, 2006, Pages 166-175

  Pellitteri, Phillip K ^a   Ferlito, Alfio ^b   Rinaldo, Alessandra ^b   Shah, Jatin P ^c   Weber, Randal S ^d   Lowry, John ^e   Medina, Jesus E ^f   Gourin, Christine G ^g   Robbins, K Thomas ^h   Suárez, Carlos ^i,j   Shaha, Ashok R ^c   Genden, Eric M ^k   Leemans, C René ^l   Lefebvre, Jean Louis ^m   Kowalski, Luiz P ⁿ   Wel, William I ^o  

^a GEISINGER MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e ROYAL BOLTON HOSPITAL   (United Kingdom)

^f UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^g MEDICAL COLLEGE OF GEORGIA   (United States)

^h SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^j DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^l VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^m CENTRE OSCAR LAMBRET   (France)

ⁿ A C CAMARGO CANCER CENTER   (Brazil)

^o UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

Advanced head and neck cancer; Cervical metastasis; Chemoradiotherapy; Planned neck dissection; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE; TUMOR MARKER;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CERVICAL LYMPH NODE; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; NECK DISSECTION; PATHOLOGY; PATIENT IDENTIFICATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; NECK DISSECTION; NEOPLASM STAGING; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 31444434686     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20302     Document Type: Review

References (49)

1. Fletcher GH. Squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1979;5:2075-2090.
2. Mendenhall WM, Million RR, Cassisi NJ. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 1986;12:733-740.
3. Barkley HT Jr, Fletcher GH, Jesse RH, Lindberg RD. Management of cervical lymph node metastases in squamous cell carcinomas of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg 1972;124:462-467.
4. Mendenhall WM, Parsons JT, Amdur RJ, Cassisi NJ, Million RR. Squamous cell carcinoma of the head and neck treated with radiotherapy: does planned neck dissection reduce the chance for successful surgical management of subsequent local recurrence? Head Neck Surg 1988;10:302-304.
5. Taylor SG 4th, Murthy AK, Vannetzel JM, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994;12:385-395.
6. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-2086.
7. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-98.
8. Adelstein DJ, Saxton JP, Lavertu P, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997;19:567-575.
9. Armstrong J, Pfister D, Strong E, et al. The management of the clinically positive neck as part of a larynx preservation approach. Int J Radiat Oncol Biol Phys 1993;26:759-765.
10. Kutler DI, Patel SG, Shah JP. The role of neck dissection following definitive chemoradiation. Oncology (Huntingt) 2004;18:993-998; discussion 999, 1003-1004, 1007.
11. Wolf GT, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992;102:934-939.
12. Dagum P, Pinto HA, Newman JP, et al. Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Am J Surg 1998;176:448-452.
13. Weisman RA, Robbins KT. Management of the neck in patients with head and neck cancer treated by concurrent chemotherapy and radiation. Otolaryngol Clin North Am 1998;3:773-784.
14. Narayan K, Crane CH, Kleid S, Hughes PG, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 1999;21:606-613.
15. Robbins KT, Wong FS, Kumar P, et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:670-675.
16. Koch WM, Lee DJ, Eisele DW, et al. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995;121:974-980.
17. Garden AS, Glisson BS, Ang KK, et al. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol 1999;17:2390-2395.
18. Corry J, Rischin D, Smith JG, et al. Radiation with concurrent late chemotherapy intensification ("chemoboost") for locally advanced head and neck cancer. Radiother Oncol 2000;54:123-127.
19. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000;126:950-956.
20. Clayman GL, Johnson CJ II, Morrison W, Ginsberg L, Lippman SM. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001;127:135-139.
21. Wanebo H, Chougule P, Ready N, et al. Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 2001;8:644-650.
22. Grabenbauer GG, Rodel C, Ernst-Stecken A, et al. Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only? Radiother Oncol 2003;66:57-63.
23. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-798.
24. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455.
25. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-1423.
26. Sapundzhiev NR, Earth PJ, Vacha P, et al. Effectiveness of radiochemotherapy on lymph node metastases in patients with stage IV oropharyngeal cancer. Oral Oncol 2004;40:1007-1016.
27. Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999;125:401-405.
28. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg 1995;121:162-165.
29. Lavertu P, Bonafede JP, Adelstein DJ, et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-406.
30. Peters LJ, Weber RS, Morrison WH, Byers RM, Garden AS, Goepfert H. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996;18:552-559.
31. Velazquez RA, McGuff HS, Sycamore D, Miller FR. The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004;130:74-77.
32. Vongtama R, Lee M, Kim B, et al. Early nodal response as a predictor for necessity of functional neck dissection after chemoradiation. Cancer J 2004;10:339-342.
33. Ojiri H, Mendenhall WM, Stringer SP, Johnson PL, Mancuso AA. Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002;52:420-428.
34. Giron J, Chisin R, Paul JL, et al. Multimodality imaging of cervical adenopathies. Eur J Radiol 1996;21:159-166.
35. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 1992;158:961-969.
36. Anzai Y, Brunberg JA, Lufkin RB. Imaging of nodal metastases in the head and neck. J Magn Reson Imaging 1997;7:774-783.
37. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255-1260.
38. Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-4208.
39. Ware RE, Matthews JP, Hicks RJ, et al. Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality following definitive treatment for squamous cell carcinoma of the head and neck. Head Neck 2004;26:1008-1017.
40. Kubota K, Yokoyama J, Yamaguchi K, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31:590-595.
41. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005;27:175-181.
42. Lowe VJ, Dunphy FR, Varvares M, et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 1997;19:666-674.
43. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 2004;58:694-697.
44. Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977;40:145-151.
45. Collins SL. Controversies in management of cancer of the neck. In: Thawley SE, Panje WR, Batsakis JG, Lindeberg RD, editors. Comprehensive management of head and neck tumors. 2nd ed. Philadelphia: W.B. Saunders Company; 1999.
46. Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg 2002;128:58-62.
47. Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001;63:202-207.
48. Robbins KT, Ferlito A, Súarez C, et al. Is there a role for selective neck dissection after chemoradiation for head and neck cancer? J Am Coll Surg 2004;199:913-916.
49. Vasan N, Krempl GA, Medina JE. Extent of "selective" neck dissection following primary radiotherapy with or without chemotherapy. In press.